Aurobindo Pharma, India’s second largest pharma company with revenues of over USD 2B, has chosen Triniti’s TRI² to govern, streamline and automate all the changes related to Oracle EBusiness Suite

Aurobindo Pharma

Why Aurobindo wanted to automate application management and eliminate manual migrations?

  • Make developers more efficient, by eliminating need to create manual migration documentation
  • Eliminate costly errors caused by mistakes in documentation and execution
  • Provide systematic audit trail and make audits and compliance economical
  • Improve end users’ trust in the overall application management

Why Aurobindo chose TRI²?

  • Make developers more productive, by eliminating the need to spend time creating migration documents
  • Complies with stringent  requirements of Pharma FDA regulations (21 CFR Part 11 Compliance) on Electronic Records and Electronic Signatures (ERES) by enforcing authentication at every approval
  • Serves as a single repository for all Aurobindo’s stakeholders -  business users, developers, IT Managers, database Administrators  and Quality/Compliance
  • Assurance to enter, view, update, and approve all changes
  • Enables Ad-hoc, event based, and scheduled migration
  • Prevents Segregation of Duties violations (such as developer cannot approve migrations)
  • Provides comprehensive audit trail that makes SOX compliance inexpensive and efficient
Wednesday, November 28, 2018

Call 866-531-9587 / Fill out the contact form.